FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| LEESAR INC | 68985-040 | 68985-040-94 | Phenylephrine HCl | Phenylephrine HCl | 40 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-004 | 68985-004-91 | Phenylephrine HCl 1mg | Phenylephrine HCl 1mg | .1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-629 | 68985-629-91 | Succinylcholine Chloride 20mg/mL | Succinylcholine Chloride 20mg/mL | 20 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-304 | 68985-304-92 | Vancomycin HCl 1.25G | Vancomycin HCl 1.25G | 5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-324 | 68985-324-93 | Vancomycin HCl 1.5G | Vancomycin HCl 1.5G | 6 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-400 | 83298-400-05 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-10-13 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-348 | 83298-348-09 | Norepinephrine Bitartrate | 8 mg/8 mL | 2025-2 | valid | 2026-10-13 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-348 | 83298-348-10 | Norepinephrine Bitartrate | 8 mg/8 mL | 2025-2 | valid | 2026-10-13 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-517 | 83298-517-10 | Oxytocin | 30 [USP'U]/3 mL | 2025-2 | valid | 2026-10-13 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 83298-348 | 83298-348-10 | Norepinephrine Bitartrate | Norepinephrine Bitartrate Injection | 8 mg/8 mL | 2025-2 | valid | 2026-09-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 83298-348 | 83298-348-09 | Norepinephrine Bitartrate | Norepinephrine Bitartrate Injection | 8 mg/8 mL | 2025-2 | valid | 2026-09-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 83298-517 | 83298-517-10 | Oxytocin | Oxytocin | 30 [USP'U]/3 mL | 2025-2 | valid | 2026-09-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 83298-400 | 83298-400-05 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-09-18 | |
| Medi-Fare Drug | 091326520 | 61141-1418 | 61141-1418-1 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2025-2 | valid | 2026-10-13 | |
| Medi-Fare Drug | 091326520 | 61141-4536 | 61141-4536-4 | Proparacaine Hydrochloride | 5 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| Medi-Fare Drug | 091326520 | 61141-1351 | 61141-1351-1 | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| Medi-Fare Drug | 091326520 | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 1.25 mg/1 mL; 2 ug/1 mL | 2025-2 | valid | 2026-10-13 | |
| Medi-Fare Drug | 091326520 | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 10 ug/1 mL | 2025-2 | valid | 2026-10-13 | |
| Medi-Fare Drug | 61141-1318 | 61141-1318-1 | Fentanyl Citrate 2500mcg/250mL (10mcg/mL) bag | Fentanyl Citrate Drip | 10 ug/1 mL | 2025-2 | valid | 2026-09-18 | |
| Medi-Fare Drug | 61141-4837 | 61141-4837-1 | Fentanyl Citrate2mcg/mL with Bupivacaine HCl 0.125%, 150ml bag | Fentanyl Citrate, Bupivacaine HCl | 1.25 mg/1 mL; 2 ug/1 mL | 2025-2 | valid | 2026-09-18 | |
| Medi-Fare Drug | 61141-1418 | 61141-1418-1 | Phenylephrine HCl 1mg/10mL (100mcg/mL) syringe | Phenylephrine HCl | 100 ug/1 mL | 2025-2 | valid | 2026-09-18 | |
| Medi-Fare Drug | 61141-4536 | 61141-4536-4 | Proparacaine HCl Repak 0.5%, 0.4ml in syringe | Proparacaine HCl Repak | 5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Medi-Fare Drug | 61141-1351 | 61141-1351-1 | Succinylcholine Chloride 200mg/10mL (20mg/mL) syringe | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Molecular PharmaGroup | 080602630 | 72790-004 | 72790-004-05 | Dehydrated Alcohol | 2.1 mL/3 mL | 2025-2 | valid | 2026-10-13 | |
| Molecular PharmaGroup | 72790-004 | 72790-004-05 | Non-proprietary | Ethanol | 2.1 mL/3 mL | 2025-2 | valid | 2026-09-18 | |
| Nephron Sterile Compounding Center, LLC | 69374-330 | 69374-330-05 | Albuterol Sulfate 0.5% | Albuterol Sulfate 0.5% | 5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Nephron Sterile Compounding Center, LLC | 69374-988 | 69374-988-10 | Amino Acid 50gm/1000ml | Amino Acid 50gm/1000ml | 5000 g/1 mL; 5000 g/1 mL | 2025-2 | valid | 2026-09-18 | |
| Nephron Sterile Compounding Center, LLC | 69374-984 | 69374-984-10 | del Nido Cardioplegia | del Nido Cardioplegia | 1.04 g/1 mL; 123 mg/1 mL; 2.19 g/1 mL | 2025-2 | valid | 2026-09-18 | |
| Nephron Sterile Compounding Center, LLC | 69374-946 | 69374-946-34 | Labetalol Hydrochloride 5 mg/mL | Labetalol Hydrochloride Injection 5 mg/mL | 5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Nephron Sterile Compounding Center, LLC | 69374-987 | 69374-987-50 | Ropivacaine Hydrochloride 200 mg/100 mL | Ropivacaine Hydrochloride 200 mg/100 mL | 2 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Nubratori Inc. | 028707055 | 71300-6638 | 71300-6638-4 | Baclofen | 50 mg/1 g | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6705 | 71300-6705-4 | Baclofen | 50 mg/1 g | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6631 | 71300-6631-1 | Dexamethasone Sodium Phosphate | 4 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6564 | 71300-6564-1 | Dexamethasone Sodium Phosphate | 4 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 3.33 mg/1 mL; 6.67 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6727 | 71300-6727-5 | Diclofenac Sodium | 100 mg | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6440 | 71300-6440-2 | Gabapentin | 100 mg/1 g | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6630 | 71300-6630-2 | Gabapentin | 100 mg/1 g | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6616 | 71300-6616-4 | Ketamine Hydrochloride | 50 mg/1 g | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6442 | 71300-6442-2 | Ketoprofen | 100 mg/1 g | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6627 | 71300-6627-2 | Ketoprofen | 100 mg/1 g | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6676 | 71300-6676-2 | Lidocaine | 75 mg/1 g | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6726 | 71300-6726-2 | Lidocaine | 75 mg/1 g | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6610 | 71300-6610-9 | Naltrexone Hydrochloride | 4.5 mg | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6610 | 71300-6610-3 | Naltrexone Hydrochloride | 4.5 mg | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6647 | 71300-6647-9 | Naltrexone Hydrochloride | 4.5 mg | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6647 | 71300-6647-3 | Naltrexone Hydrochloride | 4.5 mg | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6600 | 71300-6600-3 | Naltrexone Hydrochloride | 1.5 mg | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6600 | 71300-6600-9 | Naltrexone Hydrochloride | 1.5 mg | 2025-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 028707055 | 71300-6646 | 71300-6646-3 | Naltrexone Hydrochloride | 1.5 mg | 2025-2 | valid | 2026-10-13 |